PsyMed Ventures
Early-stage fund investing in frontier neuroscience: brain and mental health, neurotech and BCI, therapeutics, computational biology, NeuroAI, and human performance.
Funds · 1
| FUND | VINTAGE | SIZE | STATUS | DRY POWDER EST. | LPS |
|---|---|---|---|---|---|
| PsyMed Ventures Fund II, LP | 2025 | $25M | Investing | ~$18M | 18 |
Portfolio by vertical · 2 companies
■ DEEP 100%
Recent deals
No deals on record.